BridgeMD
Prevention study for Pedophilia
Official title Talking for Change: Secondary Prevention of Child Sexual Abuse Perpetration
ClinicalTrials.gov ID: NCT07001735
What this study is testing
- What it's testing
- The goal of this patient preference randomized controlled trial is to investigate the efficacy of Talking for Change (TFC), an intervention for the secondary prevention of child sexual abuse and exploitation (CSA) perpetration. Blinded clinical raters will evaluate the primary endpoint-reductions in dynamic risk factors for sexual offending against children-and clients will provide self-reports to evaluate a second primary outcome-reductions in sexual contact with children, accessing online child sexual exploitation material (CSEM), and desire for sexual contact with children.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only. Healthy volunteers may be eligible.
You may be able to join if
- For the treatment arms, the participant must meet all of the to eligible for this clinical trial:
- Must be deemed to have capacity to provide informed consent;
- Must sign and date the informed consent form;
- Stated willingness to comply with all study procedures;
- Be 18 years of age or older upon study commencement;
You likely can't join if
- For the treatment arms:
- Inability to engage meaningfully in group psychotherapy (e.g., due to intellectual disability, other neurodiversity, active psychosis or substance...
- Those who self-identify as at-risk for reasons better accounted for by non-risk-relevant factors per clinical assessment (e.g., those with...
- Non-male sex. For the benchmarking interview arm: 1\. Non-male sex.
See the full eligibility criteria
- For the treatment arms, the participant must meet all of the to eligible for this clinical trial:
- Must be deemed to have capacity to provide informed consent;
- Must sign and date the informed consent form;
- Stated willingness to comply with all study procedures;
- Be 18 years of age or older upon study commencement;
- Be referred for care in the TFC program due to concerns about enhanced risk of sexual offending against children. For the benchmarking interview arm, the participant must meet all of the following
- Must self-report concerns about enhanced risk of sexual offending against children
- Must be deemed to have capacity to provide informed consent;
- Must check the appropriate box on the informed consent form;
- Stated willingness to comply with all study procedures;
- Be 18 years of age or older upon study commencement. For the benchmarking survey arm, participants must check the appropriate box on the informed consent form.
- For the treatment arms:
- Inability to engage meaningfully in group psychotherapy (e.g., due to intellectual disability, other neurodiversity, active psychosis or substance use)
- Those who self-identify as at-risk for reasons better accounted for by non-risk-relevant factors per clinical assessment (e.g., those with obsessive-compulsive disorder including thoughts about CSA, who commonly fear...
- Non-male sex. For the benchmarking interview arm: 1\. Non-male sex.
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.